Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

NCT: NCT06047964 · ACTIVE_NOT_RECRUITING

NCT IDNCT06047964

StatusACTIVE_NOT_RECRUITING

Start Date2023-03-23

Completion2026-09-30

SponsorB. Braun Medical International Trading Company Ltd. (INDUSTRY)

First posted2023-09-21

Last updated2026-06-12

Brief Summary

This study is aiming to evaluate the safety and efficacy of SeQuent® Please CIS in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis and restenosis after interventional therapy.

Frequently Asked Questions

What is SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis?

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis is a clinical trial registered under NCT06047964. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06047964?

The current status of NCT06047964 (SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis) is: ACTIVE_NOT_RECRUITING.

When did SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis start?

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis started on 2023-03-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑